JACOB BISHOP: Open Payments
NPI 1013324136 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$54,687 in 98 payments from 7 companies in 2025. Trend: 2023 $556 · 2024 $378 · 2025 $54,687
Speaker / faculty: $43,920Consulting: $6,310Travel & lodging: $3,245Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 88 | $54,500 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Indivior Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: LYBALVI, ARISTADA, COBENFY, REXULTI, SUBLOCADE, INVEGA SUSTENNA, VRAYLAR, INGREZZA.
Industry payments across KY — which companies pay providers there.
